Fahr’s Syndrome: Rare Brain Calcification Causing Seizures in Young Adult
- Fahr's syndrome, a rare neurological condition characterized by bilateral intracranial calcifications due to metabolic abnormalities, has been diagnosed in a 30-year-old South Asian Pakistani man who presented with...
- The patient arrived at the emergency department after experiencing a generalized tonic-clonic seizure lasting approximately four minutes, accompanied by rigidity, mouth frothing, and clumsy movements, as detailed in...
- Medical literature distinguishes Fahr's syndrome from Fahr's disease, which is also known as primary familial brain calcification.
Fahr’s syndrome, a rare neurological condition characterized by bilateral intracranial calcifications due to metabolic abnormalities, has been diagnosed in a 30-year-old South Asian Pakistani man who presented with sudden-onset generalized tonic-clonic seizures, according to a case report published in Cureus.
Clinical Presentation and Neuroimaging Findings
The patient arrived at the emergency department after experiencing a generalized tonic-clonic seizure lasting approximately four minutes, accompanied by rigidity, mouth frothing, and clumsy movements, as detailed in the medical documentation. He regained consciousness within ten minutes without tongue biting or incontinence, though he also exhibited progressive cognitive decline. Neuroimaging revealed bilateral and symmetrical calcifications distributed across the basal ganglia, thalami, cerebellar dentate nuclei, periventricular regions, and centrum semiovale. Laboratory evaluations confirmed that the patient suffered from severe hypocalcemia, hypomagnesemia, and markedly reduced parathyroid hormone levels. According to the case data, these results pointed directly to hypoparathyroidism as the underlying metabolic driver of his condition.
Distinguishing Fahr’s Syndrome From Fahr’s Disease
Medical literature distinguishes Fahr’s syndrome from Fahr’s disease, which is also known as primary familial brain calcification. While Fahr’s disease is genetically inherited, Fahr’s syndrome arises secondarily from endocrine and metabolic disruptions such as hypoparathyroidism, pseudohypoparathyroidism, idiopathic hypoparathyroidism, or secondary hypoparathyroidism. First illustrated by German neurologist Karl Theodor Fahr in 1930, the syndrome involves calcium accumulation in brain regions controlling motor functions. Historical prevalence data cited in the reports suggest the condition affects males and females at an approximate ratio of 2:1, with an overall estimated prevalence of less than 1 in 1,000,000. Unlike primary genetic brain calcification, secondary Fahr’s syndrome can be partially reversible when clinicians identify and correct the underlying metabolic disturbances promptly.
Treatment and Patient Outcome
Hospital management focused on correcting the severe electrolyte and hormonal deficits identified during testing. The treatment regimen included calcium supplementation, calcitriol, vitamin D, magnesium replacement, and antiepileptic therapy. According to the published findings, this targeted medical management resulted in the successful clinical stabilization of the young adult patient.